Rapid Micro Biosystems is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Robert G. Spignesi Jr., with a market cap of $97.0M.
Common questions about Rapid Micro Biosystems
Rapid Micro Biosystems is scheduled to report earnings for Q1 2026 on May 8, 2026. Analysts estimate revenue of $7.6M.
Rapid Micro Biosystems has approximately 193 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.